Leprosy tertiary prevention

Leprosy Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Leprosy from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Criteria
History and Symptoms
Physical Examination
Laboratory Findings
X Ray
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Tertiary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Leprosy tertiary prevention On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Leprosy tertiary prevention All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Leprosy tertiary prevention
CDC on Leprosy tertiary prevention
Leprosy tertiary prevention in the news
Blogs on Leprosy tertiary prevention
Directions to Hospitals Treating Leprosy
Risk calculators and risk factors for Leprosy tertiary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: João André Alves Silva, M.D. [2]

Tertiary Prevention

Once an individual is infected with leprosy and symptoms start to develop, the longer the period to establish the correct diagnosis and treatment is started, greater the chance of developing lifetime nerve damage, skin and body in general.

References

Template:WikiDoc Sources